LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-6.79%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.04B
AUM Growth
-$670M
(-25%)
Cap. Flow
-$445M
Cap. Flow
% of AUM
-21.78%
Top 10 Holdings %
Top 10 Hldgs %
26.2%
Holding
1,109
New
341
Increased
163
Reduced
159
Closed
405
Top Buys
| 1 |
Qualcomm
QCOM
|
$166M |
| 2 |
PTC
PTC
|
$50.5M |
| 3 |
Union Pacific
UNP
|
$44.3M |
| 4 |
Norwegian Cruise Line
NCLH
|
$38.8M |
| 5 |
Biogen
BIIB
|
$36.6M |
Top Sells
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$203M |
| 2 |
GoDaddy
GDDY
|
$78.6M |
| 3 |
Dell
DELL
|
$75.6M |
| 4 |
Medpace
MEDP
|
$55.2M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$43.7M |
Sector Composition
| 1 | Technology | 24.15% |
| 2 | Healthcare | 17.85% |
| 3 | Industrials | 12.36% |
| 4 | Consumer Discretionary | 11.88% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
MGM Resorts International
MGM
$9.98B
| $1.07M | 0.02% |
43,994
+36,482
| +486% | +$885K |
|
227
JPMorgan Chase
JPM
$809B
| $1.06M | 0.02% |
10,854
-23,718
| -69% | -$2.32M |
|
228
Laureate Education
LAUR
$4.1B
| $1.05M | 0.02% |
+68,820
| New | +$1.05M |
|
229
Dianthus Therapeutics
DNTH
$853M
| $1.04M | 0.02% |
11,440
-6,318
| -36% | -$576K |
|
230
Nu Skin
NUS
$569M
| $1.04M | 0.02% |
16,973
+13,209
| +351% | +$810K |
|
231
Vistra
VST
$63.7B
| $1.01M | 0.02% |
+44,271
| New | +$1.01M |
|
232
Regions Financial
RF
$24.1B
| $1.01M | 0.02% |
75,498
-438,595
| -85% | -$5.87M |
|
233
Verizon
VZ
$187B
| $1.01M | 0.02% |
17,897
-55,166
| -76% | -$3.1M |
|
234
MDU Resources
MDU
$3.31B
| $996K | 0.02% |
109,887
+5,930
| +6% | +$53.7K |
|
235
Pfizer
PFE
$141B
| $988K | 0.02% |
23,854
+19,718
| +477% | +$817K |
|
236
Nutanix
NTNX
$18.7B
| $970K | 0.02% |
23,326
-588,278
| -96% | -$24.5M |
|
237
Estee Lauder
EL
$32.1B
| $966K | 0.02% |
7,426
+2,176
| +41% | +$283K |
|
238
Fifth Third Bancorp
FITB
$30.2B
| $958K | 0.02% |
40,702
+8,367
| +26% | +$197K |
|
239
Steven Madden
SHOO
$2.2B
| $958K | 0.02% |
+31,653
| New | +$958K |
|
240
KLA
KLAC
$119B
| $949K | 0.02% |
+10,600
| New | +$949K |
|
241
RLI Corp
RLI
$6.16B
| $946K | 0.02% |
27,412
+7,828
| +40% | +$270K |
|
242
Yum China
YUMC
$16.5B
| $938K | 0.02% |
+27,961
| New | +$938K |
|
|
BDSI
243
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $928K | 0.02% |
+251,009
| New | +$928K |
|
244
CVS Health
CVS
$93.6B
| $924K | 0.02% |
14,104
-69,285
| -83% | -$4.54M |
|
245
Twist Bioscience
TWST
$1.55B
| $924K | 0.02% |
+40,000
| New | +$924K |
|
246
Bausch Health
BHC
$2.72B
| $923K | 0.02% |
+49,960
| New | +$923K |
|
247
Hanover Insurance
THG
$6.35B
| $922K | 0.02% |
7,894
+161
| +2% | +$18.8K |
|
|
SIVB
248
DELISTED
SVB Financial Group
SIVB
| $912K | 0.02% |
4,800
-1,783
| -27% | -$339K |
|
249
Cintas
CTAS
$82.4B
| $907K | 0.02% |
+21,600
| New | +$907K |
|
250
Associated Banc-Corp
ASB
$4.42B
| $905K | 0.02% |
45,716
+11,512
| +34% | +$228K |
|